NEW YORK ( TheStreet) -- CHANGE IN RATINGS
CH Robinson (CHRW) was upgraded at Stifel Nicolaus to hold from sell. Management appears to have a solid assessment of the company's positioning, Stifel Nicolaus said.
Cummins (CMI) was upgraded at Wells Fargo to outperform from market perform. Higher end-market demand should lead to a prolonged earnings growth cycle, Wells Fargo said.
Carlisle (CSL) was upgraded at BMO Capital to outperform. Twelve-month price target is $88. Company can achieve margin and ROIC targets, BMO Capital said.
DineEquity (DIN) was upgraded at Keybanc to buy from hold. Twelve-month price target is $90. Recent pullback has created an attractive buying opportunity, Keybanc said.
Must Read: Analysts' Actions: BWLD BYD MTD TWTR
iRobot (IRBT) was downgraded at J.P. Morgan to underweight from neutral. Valuation call, based on a $32 price target, J.P. Morgan said.
Lululemon (LULU) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $56. Bulk of the bad news appears to be behind the company, and the stock is down 43% from its highs, RBC Capital said.
MWI Veterinary (MWIV) was upgraded at Piper Jaffray to overweight from neutral. Twelve-month price target is $188. IVESCO acquisition and new products should drive growth, Piper Jaffray said.
Myriad Genetics (MYGN) was upgraded at Credit Suisse to neutral from underperform. Twelve-month price target is $29. Base business can hold up better than expected and the Crescendo purchase should add to growth, Credit Suisse said.